SEC Form 4 · accession 0001834411-26-000008
AbCellera Biologics Inc. · ABCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Booth
Officer — Chief Financial Officer
Period of report
Aug 14, 2026
Accepted (ET)
Aug 14, 2026 · 12:04 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001703057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Aug 14, 2026 | P | 37,200 | $10.32 | A | 482,800 | D | |
| Common Shares | holding | — | — | — | 130,959 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.